首页> 外文会议>International Carbohydrate Symposium >GAGomic : Synthetic Tricks, Mimetics for Analytics and futur(istic) Therapeutics
【24h】

GAGomic : Synthetic Tricks, Mimetics for Analytics and futur(istic) Therapeutics

机译:露营种类:合成技巧,分析和未来(Istic)治疗方法的模拟物

获取原文

摘要

Glycosaminoglycans are linear and sulphated polysaccharides, expressed at the cell surface and displaying one of the highest information content amongst all biopolymers. As an example, the theoretical molecular diversity for Heparan Sulphate (HS) octasaccharide fragments is higher than 10~6, with the presumed aim of promoting selective interactions with HS binding proteins (HSbps). GAGomics aims at establishing new HS-protein interaction as relevant therapeutic targets. In this field, beside the fully characterized heparin/AT-III interaction,1 the elucidation of the epimerization and sulphation pattern leading to tight and specific binding of an HS fragment to a new therapeutic target is hampered by: 1) the low occurrence of such fragments at the cell surface; 2) the fact that over-sulphation often abolish the specificity of the binding without affecting its intensity.
机译:糖酰胺聚糖是在细胞表面表达的直链和硫酸化多糖,并在所有生物聚合物中显示最高信息含量之一。作为一个例子,硫酸普普(HS)十六糖片段的理论分子量高于10〜6,推测目的是促进与HS结合蛋白(HSBP)的选择性相互作用。养殖病旨在建立新的HS-蛋白质相互作用作为相关的治疗目标。在该领域,除了完全表征的肝素/ AT-III相互作用旁边,1阐明了差异和硫酸盐图案,导致HS片段紧密和特异性结合到新的治疗靶标的下降:1)较低的发生细胞表面的碎片; 2)过硫化通常废除结合的特异性而不影响其强度的事实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号